Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Jan 17, 2022 7:09pm
113 Views
Post# 34326498

RE:RE:RE:RE:Insightful1 - why are Ceo and Cfo not buying??

RE:RE:RE:RE:Insightful1 - why are Ceo and Cfo not buying?? Hard to answer a non sequitur. Do you walk to work or take your lunch? This is also a hard question to answer. The ability for MedX to sell into 38 countries is a function of their regulatory approvals not their go to market strategy. That is why it is not "on the map".

The COO question was answered appropriately given the nature of such a question. You stated you watched the SNN video and MedX was finally communicating. Perhaps you should rewatch the video or the one they did with InvestorIntel. They clearly stated all pilots are paid for to create  real-world feedback before moving to commercialization. 
<< Previous
Bullboard Posts
Next >>